Skip to Main Content

902

Views

0

CrossRef citations to date

0

Altmetric

Research Article

Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials

Joseph F. Merolaa Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
View further author information

,

April Armstrongb Division of Dermatology, University of California Los Angeles Health, Los Angeles, CA, USAView further author information

,

Saakshi Khattric Department of Dermatology, Mt. Sinai Health System, New York, NY, USAView further author information

,

So Yeon Paekd Division of Dermatology, Baylor University Medical Center, Texas A&M College of Medicine, Dallas, TX, USAView further author information

,

Byron Padillae AbbVie Inc, North Chicago, IL, USAView further author information

,

Cuiyong Yuee AbbVie Inc, North Chicago, IL, USAView further author information

,

Huzefa Photowalae AbbVie Inc, North Chicago, IL, USAView further author information

,

Blair Kaplane AbbVie Inc, North Chicago, IL, USAView further author information

&

Lars Erik Kristensenf The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Copenhagen, DenmarkView further author information